Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
156.42
+2.47 (+1.60%)
Official Closing Price
Updated: 7:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,011,993
Open
154.03
Bid (Size)
156.24 (100)
Ask (Size)
157.00 (200)
Prev. Close
153.95
Today's Range
153.90 - 156.62
52wk Range
97.72 - 156.62
Shares Outstanding
N/A
Dividend Yield
2.55%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biogen (BIIB) Q4 Earnings Preview: The "New Biogen" Emerges as Alzheimer's and Rare Disease Pipelines Take Center Stage
February 06, 2026
Biogen Inc. (NASDAQ: BIIB) reported its fourth-quarter and full-year 2025 financial results on February 6, 2026, signaling a definitive shift from a legacy company plagued by patent cliffs to a leaner,...
Via
MarketMinute
Topics
Intellectual Property
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
February 06, 2026
As of February 6, 2026, the global financial landscape is still reverberating from a historic tectonic shift that occurred in the final months of last year. In the fourth quarter of 2025, the M&A...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Performance
YTD
+12.9%
+12.9%
1 Month
+10.2%
+10.2%
3 Month
+23.8%
+23.8%
6 Month
+33.9%
+33.9%
1 Year
+46.2%
+46.2%
More News
Read More
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals
↗
January 23, 2026
Via
Chartmill
Biogen (BIIB) Deep Dive: Navigating the Pivot from MS Giant to Neuro-Innovation Powerhouse
February 06, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Arrowhead (ARWR) Q1 2026 Earnings Call Transcript
↗
February 06, 2026
Via
The Motley Fool
Topics
Earnings
Novartis (NVS) Q3 2024 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead
↗
February 04, 2026
Via
Benzinga
Topics
Intellectual Property
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook
↗
February 03, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Intellectual Property
Stocks
Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing
February 03, 2026
Via
AB Newswire
This Vanguard ETF Has Doubled the S&P 500's Returns Since the Start of 2025. Is It a Buy Now?
↗
February 03, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Peering Into Novartis AG's Recent Short Interest
↗
February 03, 2026
Via
Benzinga
The Biological Singularity: How AlphaFold 3 Is Rewriting the Blueprint of Drug Discovery
February 02, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap
↗
January 31, 2026
Via
The Motley Fool
Topics
ETFs
The Biological Singularity: How Nobel-Winning AlphaFold 3 is Rewriting the Blueprint of Life
January 28, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences
January 28, 2026
Via
MarketMinute
The Master Architect of Molecules: How Google DeepMind’s AlphaProteo is Rewriting the Blueprint for Cancer Therapy
January 27, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back
↗
January 27, 2026
Via
The Motley Fool
Topics
ETFs
Economy
The Silicon Laureates: How the 2024 Nobel Prizes Rewrote the Rules of Scientific Discovery
January 26, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?
January 26, 2026
Via
Barchart.com
Topics
World Trade
International ETFs: SPDW and SCHF Both Offer Low Cost International Exposure
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
VWO vs. SPDW: How Does a Emerging Markets ETF Fair Against a Developed World Fund?
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Novartis Positions US Strategy As Defense Against Rising Trade Levies
↗
January 23, 2026
Via
Benzinga
Topics
Government
World Trade
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Initial Public Offering
The Software Stock That Could Be 2026's Biggest Surprise
↗
January 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 156.42
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 02/06/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.